Your browser doesn't support javascript.
loading
Comments on:Benefits and risks of bisphosphonate therapy for osteoporosis / 中华内分泌代谢杂志
Chinese Journal of Endocrinology and Metabolism ; (12): 951-952, 2012.
Artículo en Chino | WPRIM | ID: wpr-430353
ABSTRACT
Bisphosphonate,as a first line medicine for treating osteoporosis,has been efficacious in reducing the incidences of fractures and some tumors.Although severe side effects such as osteonecrosis of the jaw (ONJ) and atypical fracture of femur would take place,its very low incidence does not affect the current status of bisphosphonates in the treatment of osteoporosis.

Texto completo: Disponible Índice: WPRIM (Pacífico Occidental) Tipo de estudio: Estudio de etiología Idioma: Chino Revista: Chinese Journal of Endocrinology and Metabolism Año: 2012 Tipo del documento: Artículo

Similares

MEDLINE

...
LILACS

LIS

Texto completo: Disponible Índice: WPRIM (Pacífico Occidental) Tipo de estudio: Estudio de etiología Idioma: Chino Revista: Chinese Journal of Endocrinology and Metabolism Año: 2012 Tipo del documento: Artículo